References
- Curtiss C., Cohn J.N., Vrobel T., Franciosa J.A. Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure. Circulation 58: 763–70,1978.
- Awan N.A., Amsterdam E.A., Hermanovich J., Bommer W.J., Needham K.E., Mason D.T. Long-term hemodynamic and clinical efficacy of captopril therapy in ambulatory management of severe chronic congestive heart failure. Am. Heart J. 103: 474–9, 1982.
- Captopril Multicenter Research Group. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. J. Am. Coll. Cardiol. 2: 755–63, 1983.
- Patchett A.A., Harris E., Tristram E.W. et al. A new class of angiotensin converting enzyme inhibitors. Nature 288: 280–3, 1980.
- Dahlström U., Karlberg B.E. Short and long-term effects of treatment with low dose captopril in patients with severe congestive heart failure. Br. J. Clin. Pharmac. 14:231S-235S, 1982.
- Cody R.J., Covit A.B., Schaer G.L., Laragh J.H. Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure. J. Am. Coll. Cardiol. 1(4): 1154–9, 1983.
- Fitzpatrick D., Nicholls M.G., Ikram H., Espiner E.A. Hemodynamic, hormonal, and electrolyte effects of enalapril in heart failure. Br. Heart. J. 50:163–9, 1983.